Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161441
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-11-29
Brief Title:
A Trial to Learn if the Combination of Fianlimab Cemiplimab and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-09-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-19
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-29
First Submit QC Date:
November 29 2023
Study First Post Date:
2023-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED